Literature DB >> 31368155

Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemia.

Francesco Marchesi1, Emanuela Salvatorelli2, Daniela Renzi1, Andrea Mengarelli1, Giorgio Minotti2,3, Pierantonio Menna3.   

Abstract

Entities:  

Keywords:  Ph+ ALL; efficacy; low dose; ponatinib; safety

Mesh：

Substances：

Year:  2019        PMID： 31368155     DOI： 10.1111/bjh.16132

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

Review 1.  The cancer patient and cardiology.

Authors:  José Luis Zamorano; Christer Gottfridsson; Riccardo Asteggiano; Dan Atar; Lina Badimon; Jeroen J Bax; Daniela Cardinale; Antonella Cardone; Elizabeth A M Feijen; Péter Ferdinandy; Teresa López-Fernández; Chris P Gale; John H Maduro; Javid Moslehi; Torbjørn Omland; Juan Carlos Plana Gomez; Jessica Scott; Thomas M Suter; Giorgio Minotti
Journal:  Eur J Heart Fail       Date:  2020-10-02       Impact factor: 15.534

2.  CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.

Authors:  Mathias Schneeweiss-Gleixner; Konstantin Byrgazov; Gabriele Stefanzl; Daniela Berger; Gregor Eisenwort; Chantal Blanche Lucini; Susanne Herndlhofer; Sandra Preuner; Klara Obrova; Petra Pusic; Nadine Witzeneder; Georg Greiner; Gregor Hoermann; Wolfgang R Sperr; Thomas Lion; Michael Deininger; Peter Valent; Karoline V Gleixner
Journal:  EBioMedicine       Date:  2019-11-21       Impact factor: 8.143
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.